ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

KDNY Chinook Therapeutics Inc

40,39
0,00 (0,00%)
21 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Chinook Therapeutics Inc KDNY NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 40,39 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
40,39 40,39
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
22.11.202322:15EDGAR2Form SC 13D/A - General statement of acquisition of..
21.8.202319:21EDGAR2Form 15-12G - Securities registration termination [Section..
17.8.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
11.8.202323:02EDGAR2Form S-8 POS - Securities to be offered to employees in..
11.8.202322:39EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
11.8.202322:35EDGAR2Form POS AM - Post-Effective amendments for registration..
11.8.202322:31EDGAR2Form 8-K - Current report
11.8.202322:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.8.202322:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.8.202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.8.202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.8.202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.8.202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.8.202322:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.8.202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03.8.202322:06EDGAR2Form 8-K - Current report
02.8.202301:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.8.202313:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
28.7.202314:15EDGAR2Form 8-K - Current report
28.7.202314:00GLOBEChinook Therapeutics Announces First Patient Enrolled in..
26.7.202322:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
10.7.202322:01EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
17.6.202313:15GLOBEChinook Therapeutics Presents Data from CHK-336 Phase 1..
12.6.202322:00GLOBEChinook Therapeutics to Present Updated Data from Zigakibart..
12.6.202316:40DJNTrending: Novartis Buying Chinook Therapeutics for Up to..
12.6.202314:09DJNFlurry of European Companies Engaged in Acquisitions, Asset..
12.6.202307:53DJNNovartis to Acquire Chinook Therapeutics for Up to $3.5..
12.6.202307:00GLOBEChinook Therapeutics Enters into Agreement to be Acquired by..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock